Project

GATA3-mediated epigenetic control of human T cell development

Code
01D08818
Duration
01 October 2018 → 31 October 2019
Funding
Regional and community funding: Special Research Fund
Promotor
Research disciplines
  • Natural sciences
    • Systems biology not elsewhere classified
  • Medical and health sciences
    • Hematology
    • Immunology not elsewhere classified
    • Laboratory medicine not elsewhere classified
    • Hematology not elsewhere classified
    • Autoimmunity
    • Anatomical pathology
    • Immunogenetics
Keywords
T cell development transcription factors epigenetics
 
Project description

GATA3 is an important transcription factor for the development of T lymphocytes that are important cells of the immune system. Continuing on recently published findings, in this project we wish to investigate how this protein alters epigenetic mechanisms to execute its function. Since GATA3 mutations occur in leukemia, understanding this may have important therapeutic implications.